Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to compare the testing of DNA methylation, high-risk HPV subtypes, and cytology with the definite histological results for uterine cervical lesions in a prospect...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Lei Li
NCT06254846 · Uterine Cervical Cancer
NCT06640283 · HPV-Related Carcinoma, Uterine Cervical Cancer, and more
NCT05954078 · High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, and more
NCT05231993 · Uterine Cervical Cancer
NCT04516616 · Uterine Cervical Neoplasm, Uterine Cervical Cancer, and more
Lei Li
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions